Skip to main content

Table 2 Patient baseline characteristics and treatment

From: Usefulness of the heart-rate variability complex for predicting cardiac mortality after acute myocardial infarction

Clinical features

Survivals (n = 196)

Cardiac deaths (n = 12)

Study characteristics

  

 Follow-up (months)

27.99 ± 6.02

11.17 ± 10.85

Patient characteristics

  

 Age (years)

60.19 ± 11.39

71.83 ± 7.29*

 Sex (female)

52 (27%)

6 (50%)*

 LVEF

54.86 ± 11.18

46.00 ± 11.15*

 LVEF < 0.35

9 (4.6%)

3 (25%)*

 Smoking (ex or current)

110 (56%)

4 (33%)*

 Diabetes mellitus

42 (21%)

8 (67%)*

 Previous myocardial infarction

25 (13%)

2 (17%)

 Hypertension

95 (48%)

11 (92%)*

Treatment

  

 PTCA

117 (60%)

7 (58%)

 Thrombolysis

44 (22%)

2 (17%)

 No acute revascularization

35 (18%)

3 (25%)

 Aspirin or clopidogrel

194 (99%)

12 (100%)

 β-blockers

158 (81%)

10 (83%)

 Statins

192 (98%)

10 (83%)*

 ACEI/ARB

150 (77%)

9 (75%)

 Diuretic

134 (68%)

7 (58%)

  1. Data are number (%) unless otherwise stated. *P < 0.05.